Search results
Author(s):
Mikhail Kosiborod
Added:
8 months ago
HFSA 24 - We are joined virtually by Dr Mikhail Kosiborod (Saint Luke’s Mid America Heart Institute, US) to discuss findings from the STEP-HFpEF trial programme in regard to the efficacy of semaglutide according to frailty status, and exercise function at baseline.Interview Questions:1. Could you remind us of the importance of STEP-HFpEF2. What was the study design and patient population?3. What…
View more
Author(s):
Anastasia Shchendrygina
,
Amina Rakisheva
,
Ilya Giverts
,
et al
Added:
9 months ago
Iron Deficiency in LVAD Patients
Author(s):
William Herrik Nielsen
,
Finn Gustafsson
Added:
11 months ago
Article
Author(s):
Jasper J Brugts
,
Harriette Van Spall
Added:
1 year ago
HFA 24 - Late-breaker host, Dr Harriette Van Spall (McMaster University, CA) joined onsite by Dr Jasper Brugts (Erasmus University Medical Centre, NL) to discuss the first results from the TITRATE-HF study.TITRATE-HF is a real-world multicenter longitudinal study which aims to assess drug sequencing strategies for guideline-directed medical therapy (GDMT) initiation in patients with de novo,…
View more
New Insights on HFpEF Treatment
Author(s):
Giulio Balestrieri
,
Raul Limonta
,
Enrico Ponti
,
et al
Added:
1 year ago
Article
Author(s):
Karol Mirkowski
,
Ercole Vellone
,
Bernadetta Żółkowska
,
et al
Added:
3 months ago
Peter H Brubaker
Job title: Professor in the Department of Health and Exercise Science and Executive Director of Healthy Exercise and Lifestyle ProgramS (HELPS)
Author
Jamie M O’Driscoll
Job title: Reader in Cardiovascular Physiology
Author
Author(s):
Marat Fudim
Added:
3 months ago
THT Conference 2025 - Findings show catheter ablation of the right greater splanchnic nerve (GSN) in patients with heart failure with preserved ejection fraction (HFpEF) reduced estimated stressed blood volume in patients whether the ablation caused clinical benefits or not. This outcome indicates a confirmation of technical success that correlates with prior single-arm study findings.Dr Marat…
View more
Author(s):
Purvi Parwani
Added:
1 year ago
AHA 23 — Dr Purvi Parwani, cardiologist and multimodality imager, and director of the Women's Heart Clinic at Loma Linda University Health in the US, spotlights three game-changing late-breaking science trials from the AHA Scientific Sessions. Discover the trials anticipated to reshape clinical practices as Dr Parwani shares her insights.Trials discussed in detail include:POP-HT: Cardiac…
View more